Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Contract research organization Toxikon provides nonclinical testing services for pharma, biotech and medtech companies, supporting their safety and efficacy studies of new drugs and devices. (Labcorp) ...
Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...
BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test ...
BURLINGTON, N.C.--(BUSINESS WIRE)--For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications ...
The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...
Laboratory Corporation of America Holdings, or LabCorp LH, is gaining from strength in its Drug Development business. The company’s strong fourth-quarter performance instils optimism. However, stiff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results